• Taysha Gene Therapies granted five new employees 314,000 restricted stock units, representing shares of common stock.
• It also issued options covering 92,400 common shares, priced at USD 5.7 per share, matching the grant-date close.
• RSUs vest in four equal annual installments starting on the first anniversary, subject to continued service.
• Options run for 10 years, vesting over four years with 25% after year one, then monthly over 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Taysha Gene Therapies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609040800PRIMZONEFULLFEED9821349) on September 04, 2026, and is solely responsible for the information contained therein.